ROARABLE
FREE $100K
My Trading Account →
▾
Trading Profile Active
Active Trader
Verified Trader
⚡ My $100K Trading Account → ★ My Saved Watchlist →
🟢 My $100K Account → Today Screener Big Ideas Track Record 💰 $100K Arena 🎲 Predictions 🏛️ Insiders 8 Analysts
Stock Ratings / Health Care / BFRG / news
PTN (35) INM (47) CMMB (31) MBRX (34) ⌘ Pro Terminal →

Why BFRG Stock advanced +1.78% Today — RQD Quant Desk Flash

$0.50 +1.78% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $0.50

Bullfrog AI Holdings Inc. (BFRG) carries a Roarable Rating of E (Strong Sell) with 32/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE E • RED ALERT Cap $9.0M
📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on BFRG Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is BFRG stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼

As of 2026-11-03, Bullfrog AI Holdings Inc. (NASDAQ: BFRG) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 32/100 at a spot price of $0.50 (+1.78% 1D, market cap $9.0M). Pillar breakdown: Fundamental Cash Engine 6/20, Institutional 13F & Options Flow 9/20, SEC Balance-Sheet Forensics 8/20, FRED Macro Regime Fit 6/20, and Executive Insider Alignment 3/20. Across 1015 tracked Health Care issuers, BFRG ranks #741 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does BFRG compare to PTN and INM in the Health Care sector?
▼

Within the Health Care sector (Biotechnology: Pharmaceutical Preparations), BFRG carries a Roarable E (32/100 RQD), trailing P/E of N/A, gross margin of 18.8%, and ROIC of -35.0%. By comparison, PTN (Palatin Technologies Inc.) holds a D- grade (35/100 RQD, P/E N/A, ROIC -35.0%, cap $8.9M) and INM (InMed Pharmaceuticals Inc.) posts a D grade (47/100 RQD, P/E N/A, ROIC -35.0%, cap $8.8M). Among the 5-stock peer group, BFRG leads on earnings multiple (N/A) while BFRG leads on capital efficiency (-35.0% ROIC).

✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for BFRG?
▼

Per BFRG's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001829247), Bullfrog AI Holdings Inc. generated $116.7K in revenue (-99.4% YoY), -$6.5M in net income, and -$5.5M in free cash flow against $2.8M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
🛡️ Portfolio Crash X-Ray
EXT / AFTER-HRS: $0.50 (+0.13%)🧬 Dilution Drag (+1.28% YoY Shares)⚙️ Cash Engine: 6/20 (E) • 0% FCF Margin
Verify 90D Bucket Audit →
📊 Historical Track Record Warning: Scores below 50 (32/100 · E) historically underperformed SPY in 71% of rolling 90-day windows (-9.2% avg 90D alpha vs SPY • 29.0% hit rate).
Audit Bucket Track Record →
RQD QUANT TACHOMETERRED ALERT • E
025507510032
3-of-3 JEV AI Jury Bearish Warning
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw E · Rk D-
Cash (6)Whales (9)SEC (8)Macro (6)CEO (3)
Each axis scored 0–20
12M PRICE TARGET CONE-12% Base Target
$2 Bull$0 Base$0 Bear
📬 FREE BFRG RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for BFRG)Realized 20D OHLCV Swing Band: ±12.5%
Deterministic 5-Pillar Attribution (32/100 Composite)
🔍 WHY BFRG SCORES 32/100 (E) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: Whale & Options Positioning+9/20 pts (28% of score)

20D Institutional Volume Accumulation (±12.5% realized swing band)

▲ #2 Bullish Driver: SEC 10-K Forensic Risk+8/20 pts (25% of score)

Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 3/9

▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution4/20 pts (-16 pt drag)

Dilution Drag (+1.28% YoY Shares) & executive Form 4 sales trim 16 pts from alignment

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)
40
Grade D$0.57-14% Next Q
Q2 (-2Q)
37
Grade E$0.49-4.1% Next Q
Q3 (-1Q)
35
Grade E$0.47+6.4% Next Q
Current
32
Grade E$0.50-9.2% Hist 90D α
Trajectory: D (40) → E (32)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a BFRG Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While BFRG currently carries a cautious 32/100 (E) rating due to Insider Conviction & Share Dilution (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Health Care with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($0.55) and Max Pain ($0.53) forces dealer call-delta covering toward $2.06.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Dilution Drag (+1.28% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $BFRG• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “BFRG Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
YES 32%NO 68%Trade / Inspect Odds →
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →

Why BFRG Stock advanced +1.78% Today — RQD Quant Desk Flash

Bullfrog AI Holdings Inc. (BFRG) advanced +1.78% to $0.50, trading at 5% of its 52-week range ($0.43 – $1.96). Stretched risk/reward at current multiples (-35% return on capital) under elevated 10-year interest-rate pressure.

  • ▸Technical Tape: Trading at 5% of its 52-week range ($0.43 – $1.96) with RSI-14 at 43.9 (NEUTRAL RANGE).
  • ▸Volatility Profile: Historical 20-day realized swing band of ±12.5% around $0.50 (no active unusual options sweep snapshot on file).
  • ▸Fundamental Anchor: Roarable E (Strong Sell) backed by 2.2% gross margin and $0 annual free cash flow.
Live BFRG Headlines & Catalysts
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring BFRG)

  • ✓Walkthrough of BFRG's RQD Radar, SEC cash-conversion gap & downside invalidation levels
  • ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
  • ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
Join Founding VIP Waitlist (No Card Required) →$100K Arena
BFRG // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -27.54%📐 HORIZONTAL RANGE
2026-11-03O $0.51H $0.51L $0.49C $0.50VOL 125.2K
RES: $1.14SUP: $0.33SMA50: $0.55SMA200: $0.65
$1.09$0.91$0.73$0.55$0.37RES $1.14SUP $0.33$0.502026-05-042026-06-172026-08-042026-09-182026-11-03
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

BFRG Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 BFRG Butterfly Map → + Track BFRG →
Share Count & Dilution Monitor

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle
8.0%/yr Implied 5Y Growth

vs. -99.4% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger

No active Ellis Vennor swing setup published on BFRG today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for BFRG. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for BFRG today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (BFRG)

Health Care Rank #741 of 1015 ⚔️ PTN vs BFRG Full Matrix →

1. Head-to-Head Health Care Peer Comparison (BFRG vs. PTN, INM, CMMB, MBRX)

Industry: Biotechnology: Pharmaceutical Preparations (489 Tracked Issuers)

Across 1015 tracked Health Care securities in the Roarable RQD universe, Bullfrog AI Holdings Inc. (BFRG) ranks #741 by composite RQD confidence (32/100, grade E) and #900 by equity capitalization ($9.0M). Within this direct 5-issuer industry benchmark cohort, BFRG leads on earnings valuation at N/A trailing P/E, while BFRG leads on capital efficiency and profitability with -35.0% ROIC and 18.8% gross margin. INM currently holds the highest overall quantitative score in the immediate peer group at 47/100 (D) compared with BFRG at 32/100 (E).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
BFRG ACTIVE
Bullfrog AI Holdings Inc.
E 32/100 — 18.8% -35.0% +1.78% $9.0M Benchmark Subject
PTN
Palatin Technologies Inc.
D- 35/100 — — -35.0% -0.20% $8.9M /ptn-vs-bfrg →
INM
InMed Pharmaceuticals Inc.
D 47/100 — 34.5% -35.0% +1.88% $8.8M /inm-vs-bfrg →
CMMB
Chemomab Therapeutics Ltd.
E 31/100 — — -35.0% +1.72% $9.3M /cmmb-vs-bfrg →
MBRX
Moleculin Biotech Inc.
E 34/100 — — -35.0% +5.32% $8.3M /mbrx-vs-bfrg →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001829247 ↗

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Bullfrog AI Holdings Inc. (BFRG) reported GAAP revenue of $116.7K (-99.4% vs. FY2024 revenue of $20.3M , and +79.5% cumulative change since FY2023) , GAAP net income of -$6.5M, operating cash flow of -$5.5M, and free cash flow of -$5.5M (+1.6% YoY). On the balance sheet, BFRG closed FY2025 with $2.8M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 3/9).

Fiscal Period Filing Date Revenue Net Income Operating Cash Flow Free Cash Flow Total Assets Total Debt
FY2025 (FY) 2025-12-31 $116.7K -$6.5M -$5.5M -$5.5M $2.8M —
FY2024 (FY) 2024-12-31 $20.3M -$7.0M -$5.6M -$5.6M $5.6M —
FY2023 (FY) 2023-12-31 $65.0K -$5.4M -$6.0M -$6.0M — —

3. BFRG Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is BFRG stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-03, Bullfrog AI Holdings Inc. (NASDAQ: BFRG) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 32/100 at a spot price of $0.50 (+1.78% 1D, market cap $9.0M). Pillar breakdown: Fundamental Cash Engine 6/20, Institutional 13F & Options Flow 9/20, SEC Balance-Sheet Forensics 8/20, FRED Macro Regime Fit 6/20, and Executive Insider Alignment 3/20. Across 1015 tracked Health Care issuers, BFRG ranks #741 in composite RQD confidence.

How does BFRG compare to PTN and INM in the Health Care sector?

Within the Health Care sector (Biotechnology: Pharmaceutical Preparations), BFRG carries a Roarable E (32/100 RQD), trailing P/E of N/A, gross margin of 18.8%, and ROIC of -35.0%. By comparison, PTN (Palatin Technologies Inc.) holds a D- grade (35/100 RQD, P/E N/A, ROIC -35.0%, cap $8.9M) and INM (InMed Pharmaceuticals Inc.) posts a D grade (47/100 RQD, P/E N/A, ROIC -35.0%, cap $8.8M). Among the 5-stock peer group, BFRG leads on earnings multiple (N/A) while BFRG leads on capital efficiency (-35.0% ROIC).

What are the biggest fundamental strengths and SEC risk factors for BFRG?

Per BFRG's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001829247), Bullfrog AI Holdings Inc. generated $116.7K in revenue (-99.4% YoY), -$6.5M in net income, and -$5.5M in free cash flow against $2.8M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.

Where is BFRG trading relative to its 50-day, 200-day, and 52-week technical levels?

BFRG last traded at $0.50 (+1.78% on volume of 156,981 shares), positioning the stock -9.09% below its 50-day simple moving average ($0.55) and -23.08% below its 200-day simple moving average ($0.65). Across its 52-week range of $0.43 to $1.96, BFRG sits at the 4.6% percentile with a 14-day RSI of 43.9 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($1.00 to $0.56).

Direct Sub-Reports: BFRG RQD Cockpit BFRG 12M Forecast BFRG Earnings & Move BFRG Dividends & DRIP BFRG Insiders & 13F BFRG Whale Options BFRG Profit Sankey BFRG News & Why
ROARABLE RATING BRIEF • RQD 32/100 (E) ✓ SEC XBRL & RQD VERIFIED

BFRG — Bullfrog AI Holdings Inc.: What the Facts Mean to a Prospective Investor

Methodology: RQD v6.2 Deterministic 5-Pillar & SEC XBRL Audit
Updated: 2025-12-31

1. Roarable Rating Brief: What This Means to a Prospective Investor

Bullfrog AI Holdings Inc. (BFRG) earns a live Roarable RQD composite score of 32/100, corresponding to a E letter grade (Roarable Strong Sell) at a spot price of $0.50 (+1.78% 1D, market capitalization $9.0M).

  • Fundamental Cash Engine (6/20): Anchored by return on invested capital (ROIC) of -35.0%, gross margin of 18.8%, operating margin of -60.0%, and free cash flow yield of —.
  • Whale 13F & Options Flow (9/20) + Insider Conviction (3/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
  • Macro Regime Fit (6/20) + Forensic Balance Sheet (8/20): Incorporates a 1.00x equity beta, Altman Z-Score of N/A, Piotroski F-Score of 3/9, and Debt/Equity of N/A.

2. Business Model, Unit Margins & SEC Financial Trajectory

Bullfrog AI Holdings Inc. (BFRG) is a NASDAQ-listed issuer in the Health Care sector, operating in the Biotechnology: Pharmaceutical Preparations industry. Revenue for the reported periods is small, at $0.1M, —, and $0.1M.

In its latest audited SEC EDGAR 10-K filing for FY2025 (filed 2025-12-31), Bullfrog AI Holdings Inc. (BFRG) reported $116.7K in annual revenue (up from $20.3M in FY2024, -99.4% YoY) and -$6.5M in GAAP net income. Over the multi-year SEC filing window from FY2023 ($65.0K revenue, -$5.4M net income) through FY2025, BFRG scaled operating cash flow to -$5.5M and free cash flow to -$5.5M, backed by $2.8M in total assets against $0 in total debt.

3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff

  • 🐂 Primary Bull Case (E • RQD 32/100): Established market leader in Health Care with deep daily trading liquidity. Free cash flow yield of — and institutional whale pillar of 9/20. With Fundamental Cash Engine at 6/20 and Institutional Whale Flow at 9/20, sustained execution supports upside toward the upper end of the $0.43 – $1.96 52-week range.
  • 🐻 Primary Bear Case & Valuation Risk: Company executives have done more routine share selling than personal cash buying lately. Investors must weigh current valuation against -60.0% operating margins and a 1.00x macro beta.

4. 2nd-Order Butterfly Ripples & Key Questions to Watch

The source data therefore does not establish upstream suppliers, downstream customers, or sector correlations beyond the classification of Health Care / Biotechnology. The 2nd-order item an investor should track is the pharma partnership itself: because the company's revenue is only $0.

  • Key Question #1: Can BFRG sustain or expand its -60.0% operating margin and -35.0% ROIC against Biotechnology: Pharmaceutical Preparations peers over the next 4 quarters?
  • Key Question #2: Following FY2025 revenue of $116.7K and free cash flow of -$5.5M, how will capital allocation balance growth reinvestment against $0 in total debt?
  • Key Question #3: How sensitive is BFRG's equity valuation to Health Care capital spending cycles and macro interest-rate shifts (Beta 1.00x)?

BFRG Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Bullfrog AI Holdings Inc. (BFRG) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to BFRG Debate Forum (3) ↓
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

BFRG Bull vs. Bear Conversation Board — What's Your Call at $0.50?

🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON BFRG 🐻 33% BEARISH CONVICTION
1. Pick Your Side on BFRG:
💡 Tip: Back up your call with a price target or RQD metric to get upvoted to the top.
CA CashFlowKing RQD DEBATE OPENER • FCF Compounder Hunter 🐂 BULLISH 🎯 Target: $0.61 (+24.5%)
📌 Pinned Debate

A pharma partnership on an AI drug-discovery program is cited in recent news as a growth catalyst for a company trading near $0.51.

Here is why I am bullish on BFRG here at $0.49: A pharma partnership on an AI drug-discovery program is cited in recent news as a growth catalyst for a company trading near $0.51.. Compare BFRG's -60.0% operating margin and -35.0% ROIC against the rest of Biotechnology: Pharmaceutical Preparations. As long as cash conversion holds up, dips toward $0.47 are getting bought.

RetailWhale_TX 🐂 BULL

Both sides have a point here — BFRG's 8/20 balance sheet score keeps downside contained, so the real swing factor next earnings call is backlog and FCF conversion.

SH ShortSeller_Dan RQD DEBATE OPENER • Forensic Short Bias 🐻 BEARISH 🎯 Target: $0.42 (-14.3%)
Spot @ $0.49

Reported operating margin of -60%, ROIC of -35%, and FCF of -$5.5M against $2.2M cash leave little internal support for the stock.

Sitting on the sidelines or leaning short BFRG above $0.49. Reported operating margin of -60%, ROIC of -35%, and FCF of -$5.5M against $2.2M cash leave little internal support for the stock.. Until Fundamental Cash Engine (6/20) and FCF yield (0.0%) inflect higher, upside is capped near $1.96.

LIVE TAPE